Rocket Pharmaceuticals, Inc. Public Float
Rocket Pharmaceuticals, Inc. (RCKT) had Public Float of $212.50 million as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $212.50M.
- 2024-06-30: Entity Public Float $1.40B.
- 2023-06-30: Entity Public Float $1.20B.
- 2022-06-30: Entity Public Float $644.30M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $212.50M 10-K · filed 2026-02-26 |
| 2024-06-30 | $1.40B 10-K · filed 2025-02-27 |
| 2023-06-30 | $1.20B 10-K · filed 2024-02-27 |
| 2022-06-30 | $644.30M 10-K · filed 2023-02-28 |
| 2021-06-30 | $1.90B 10-K · filed 2022-02-28 |
| 2020-06-30 | $734.60M 10-K · filed 2021-03-01 |
| 2019-06-28 | $462.50M 10-K · filed 2020-03-06 |
| 2018-06-30 | $428.90M 10-K · filed 2019-03-08 |
| 2017-06-30 | $45.40M 10-K · filed 2018-03-07 |
| 2016-06-30 | $43.80M 10-K · filed 2017-03-16 |
| 2015-06-30 | $21.50M 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |